Written from the source article · ◎ = company's stated target · Not investment advice
A peer-reviewed Letter to the Editor in The New England Journal of Medicine reported updated long-term findings from the investigator-sponsored, first-in-human transplant of UP421 HIP-modified primary islet cells, consis
Create a free account to read the full summary, key facts and the original source for every signal.
Create a free accountEvery Monday: up to 5 major breakthroughs and launches, explained in plain English. Free. No account needed.
One email a week. Unsubscribe anytime.